Virginia Opioid Overdose Treatment InitiatVE

PHASE3TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 4, 2019

Primary Completion Date

February 24, 2021

Study Completion Date

February 24, 2021

Conditions
Opioid Use Disorder
Interventions
DRUG

SUBLOCADE

SUBLOCADE (buprenorphine extended-release) injection is a colorless to amber sterile solution for SC injection designed to deliver buprenorphine at doses of 100 mg or 300 mg at a controlled rate over a one-month period.

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Indivior, PLC.

UNKNOWN

lead

Virginia Commonwealth University

OTHER

NCT03818399 - Virginia Opioid Overdose Treatment InitiatVE | Biotech Hunter | Biotech Hunter